Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	26,218	15,737	15,752	6,435	5,427	4,964	Upgrade
Market Cap Growth	-0.10%	-0.10%	144.77%	18.58%	9.32%	80.88%	Upgrade
PE Ratio	25.26	15.16	17.29	7.32	6.36	6.15	Upgrade
PS Ratio	17.36	10.16	11.55	4.83	4.15	3.85	Upgrade
PB Ratio	2.16	1.29	1.45	0.63	0.58	0.63	Upgrade
P/FCF Ratio	37.62	22.58	-	-	3.96	-	Upgrade
P/OCF Ratio	37.28	22.37	-	-	3.91	-	Upgrade
Debt / Equity Ratio	0.71	0.71	0.90	0.98	1.36	1.72	Upgrade
Debt / FCF Ratio	12.37	12.37	-	-	9.30	-	Upgrade
Quick Ratio	720.98	720.98	11.71	6.95	3.46	4.40	Upgrade
Current Ratio	726.55	726.55	11.87	7.04	3.50	4.46	Upgrade
Asset Turnover	0.07	0.07	0.07	0.06	0.06	0.06	Upgrade
Return on Equity (ROE)	9.00%	9.00%	8.65%	9.00%	9.87%	10.45%	Upgrade
Return on Assets (ROA)	4.93%	4.93%	4.39%	4.10%	3.85%	3.65%	Upgrade
Earnings Yield	3.96%	6.60%	5.78%	13.67%	15.72%	16.26%	Upgrade
Earnings Yield	3.96%	6.60%	5.78%	13.67%	15.72%	16.26%	Upgrade
FCF Yield	2.66%	4.43%	-0.45%	-21.27%	25.23%	-34.55%	Upgrade
Dividend Yield	1.02%	1.77%	1.48%	3.52%	2.12%	1.39%	Upgrade
Payout Ratio	22.30%	22.30%	23.81%	12.33%	7.57%	-	Upgrade
Buyback Yield / Dilution	-2.47%	-2.47%	-	-5.99%	-5.64%	-	Upgrade
Total Shareholder Return	-1.45%	-0.71%	1.48%	-2.47%	-3.52%	1.39%	Upgrade

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.